Because the C-terminal region of TRIM29 (amino acids 267–588) is retained in the SPON1-TRIM29 fusion protein, it is possible that the molecule drives stress resistance in ovarian cancer cells in a dominant-positive manner. This evidence concerns the gene TRIM29 and ovarian carcinoma.